HopeStage
Back to all studies
SuspendedNCT05567848

Accelerated TMS in Psychosis

Device studyAges 18–65United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 29, 2022
Recruitment status
Suspended
Enrollment listed in the registry
20
Sponsor
Beth Israel Deaconess Medical Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05567848
Official title
Show the full official title

Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders

Recruitment & locations

Suspended

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Beth Israel Deaconess Medical Center, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies